Revuelta M, Romero-Ramos M, Venero J L, Millan F, Machado A, Cano J
Departamento de Bioquímica, Bromatología y Toxicología, Facultad de Farmacia, Universidad de Sevilla, Spain.
Neuroscience. 1997 Mar;77(1):167-74. doi: 10.1016/s0306-4522(96)00491-5.
The effect of ascorbic acid depletion on the 1-methyl-4-phenylpyridinium ion (MPP+)-induced neurotoxicity in the dopaminergic system has been tested in guinea-pig striatal slices. Guinea-pigs were divided into three groups and fed on a control diet, ascorbic acid-free diet and ascorbic acid-supplemented diet, respectively. Diets were maintained during 30 days. Striatal slices from ascorbic acid-deficient animals showed the highest levels of dopamine following 25 microM MPP+ treatment; the results from animals under this treatment condition were statistically different from both control and ascorbic acid-supplemented animals under identical experimental conditions. In addition, neurochemical analysis demonstrated that the levels of ascorbic acid and dehydroascorbic acid were highly reduced in striatal tissue from ascorbic acid-deficient animals, thus proving scorbutic conditions in our experimental animals. In view of the higher resistance of the ascorbic acid-deficient animals to the neurotoxicity elicited by MPP+, additional dopaminergic parameters were also measured in striatal tissue from ascorbic acid-deficient animals in the absence of MPP+, including levels of dopamine and its metabolites, tyrosine hydroxylase activity and dopamine uptake, with the aim of finding an explanation for this unexpected result. While dopamine levels and tyrosine hydroxylase activity remained close to control levels, dopamine uptake was significantly reduced in striatal synaptosomes from ascorbic acid-deficient animals as compared with control animals. Since MPP+ is actively accumulated into dopaminergic nerve terminals via the high-affinity dopamine uptake system, this finding could explain the higher resistance of ascorbic acid-deficient animals to the dopamine-depleting effect induced by MPP+ toxicity assayed in striatal slices.
在豚鼠纹状体切片中测试了抗坏血酸耗竭对1-甲基-4-苯基吡啶离子(MPP+)诱导的多巴胺能系统神经毒性的影响。将豚鼠分为三组,分别喂食对照饮食、无抗坏血酸饮食和补充抗坏血酸的饮食。饮食持续30天。用25 microM MPP+处理后,来自抗坏血酸缺乏动物的纹状体切片显示多巴胺水平最高;在相同实验条件下,该处理条件下动物的结果与对照动物和补充抗坏血酸动物的结果在统计学上有差异。此外,神经化学分析表明,抗坏血酸缺乏动物纹状体组织中抗坏血酸和脱氢抗坏血酸的水平大幅降低,从而证明我们的实验动物存在坏血病状态。鉴于抗坏血酸缺乏动物对MPP+引起的神经毒性具有更高的抵抗力,还在没有MPP+的情况下测量了抗坏血酸缺乏动物纹状体组织中的其他多巴胺能参数,包括多巴胺及其代谢物的水平、酪氨酸羟化酶活性和多巴胺摄取,旨在为这一意外结果找到解释。虽然多巴胺水平和酪氨酸羟化酶活性仍接近对照水平,但与对照动物相比,抗坏血酸缺乏动物纹状体突触体中的多巴胺摄取显著降低。由于MPP+通过高亲和力多巴胺摄取系统被主动积累到多巴胺能神经末梢中,这一发现可以解释抗坏血酸缺乏动物对纹状体切片中MPP+毒性诱导的多巴胺耗竭效应具有更高抵抗力的原因。